ArticleACS omega2024
Synthesis of Lead(II) Carbonate-Containing Nanoparticles Using Ultrasonication or Microwave Irradiation.
Article in ACS omega, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report on the synthesis of lead(II) carbonate-containing nanoparticles using the polyol process under high-energy ultrasound or microwave irradiation as alternate energization methods. Five carbonate source precursors are used in the reaction, and the precipitation reactions generate four different crystal products, depending on the precursor. More alkaline precursors produce the hydroxy-carbonate structures (abellaite, or its potassium analog, and hydrocerussite), while the less alkaline precursors produce the simple carbonate structure (cerussite). Ultrasonication or microwave irradiation during the arrested precipitation ensures the formation of nanoparticles <100 nm in diameter in a mostly single crystalline phase in all cases, bar one. The products were characterized by powder X-ray diffraction, dynamic light scattering, electron microscopy, infrared spectroscopy, and thermal analysis. These nanoparticles are targeted as X-ray contrast agents for biological imaging, particularly of fine vasculature where small particle size is essential.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.